MAZ2 performed better than auranofin at its own IC50, and far better than the DAZ2 and TAZ2 structures, containing two and three methoxyls, respectively, which provided evidence of MAZ2′s stronger anti-cancer proliferation efficiency (Table 1). This evidence concerns the gene DAZ2 and cancer.